⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XERS News
Xeris Biopharma Holdings, Inc. Common Stock
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Form 8-K
sec.gov
XERS
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
businesswire.com
XERS
Form 8-K
sec.gov
XERS
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
XERS
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
XERS
Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Xeris Announces Updates to Its Board of Directors
businesswire.com
XERS